HEADER HYDROLASE 31-MAR-03 1OEW TITLE ATOMIC RESOLUTION STRUCTURE OF NATIVE ENDOTHIAPEPSIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENDOTHIAPEPSIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 90-419; COMPND 5 SYNONYM: ASPARTATE PROTEASE, EAPA, EPN-1; COMPND 6 EC: 3.4.23.22; COMPND 7 OTHER_DETAILS: SHORT PEPTIDE (MODELLED AS SER-THR) BOUND NON- COMPND 8 COVALENTLY IN THE ACTIVE SITE CLEFT SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CRYPHONECTRIA PARASITICA; SOURCE 3 ORGANISM_COMMON: CHESTNUT BLIGHT FUNGUS; SOURCE 4 ORGANISM_TAXID: 5116 KEYWDS HYDROLASE, ASPARTIC PROTEINASE MECHANISM, ATOMIC RESOLUTION, KEYWDS 2 SUCCINIMIDE, ANISOTROPIC REFINEMENT EXPDTA X-RAY DIFFRACTION AUTHOR L.COATES,P.T.ERSKINE,S.MALL,R.S.GILL,S.P.WOOD,D.A.A.MYLES,J.B.COOPER REVDAT 7 15-NOV-23 1OEW 1 REMARK LINK ATOM REVDAT 6 24-JUL-19 1OEW 1 REMARK REVDAT 5 10-JUL-19 1OEW 1 REMARK REVDAT 4 20-JUN-18 1OEW 1 REMARK LINK REVDAT 3 24-FEB-09 1OEW 1 VERSN JRNL REMARK MASTER REVDAT 2 31-JUL-03 1OEW 1 JRNL REVDAT 1 02-APR-03 1OEW 0 JRNL AUTH P.T.ERSKINE,L.COATES,S.MALL,R.S.GILL,S.P.WOOD,D.A.A.MYLES, JRNL AUTH 2 J.B.COOPER JRNL TITL ATOMIC RESOLUTION ANALYSIS OF THE CATALYTIC SITE OF AN JRNL TITL 2 ASPARTIC PROTEINASE AND AN UNEXPECTED MODE OF BINDING BY JRNL TITL 3 SHORT PEPTIDES JRNL REF PROTEIN SCI. V. 12 1741 2003 JRNL REFN ISSN 0961-8368 JRNL PMID 12876323 JRNL DOI 10.1110/PS.0305203 REMARK 2 REMARK 2 RESOLUTION. 0.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 0.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 100.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.121 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.147 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 9383 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 186749 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : NULL REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.115 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.141 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 4.400 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 8243 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 163167 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2388 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 45 REMARK 3 SOLVENT ATOMS : 609 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : NULL REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : NULL REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 34 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 27802 REMARK 3 NUMBER OF RESTRAINTS : 34005 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.015 REMARK 3 ANGLE DISTANCES (A) : 0.029 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.032 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.085 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.100 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.121 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.006 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.030 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.081 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: MOEWS AND KRETSINGER REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1OEW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 31-MAR-03. REMARK 100 THE DEPOSITION ID IS D_1290012409. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-JUN-99 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : EMBL/DESY, HAMBURG REMARK 200 BEAMLINE : BW7B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.8439 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 186749 REMARK 200 RESOLUTION RANGE HIGH (A) : 0.910 REMARK 200 RESOLUTION RANGE LOW (A) : 42.300 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 4.700 REMARK 200 R MERGE (I) : 0.10900 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 8.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 0.91 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 0.96 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.4 REMARK 200 DATA REDUNDANCY IN SHELL : 3.40 REMARK 200 R MERGE FOR SHELL (I) : 0.50300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER REMARK 200 SOFTWARE USED: SHELXL-97 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.99 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: BATCH METHOD WITH ENZYME AT A REMARK 280 CONCENTRATION OF 2 MG/ML IN 100 MM SODIUM ACETATE BUFFER AT PH REMARK 280 4.6 (MOEWS AND BUNN, 1970) CRYSTALS LEFT TO GROW FOLLOWING SLOW REMARK 280 ADDITION OF AMMONIUM SULPHATE TO FINAL CONCENTRATION OF 0.35 G/ REMARK 280 ML (55% SATURATION). REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 37.33000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 CATALYSES THE HYDROLYSIS OF PROTEINS WITH BROAD SPECIFICITY REMARK 400 THE ACTIVITY OF THIS PROTEIN IS SIMILAR TO PEPSIN A, SINCE REMARK 400 IT PREFERS HYDROPHOBIC RESIDUES AT P1 AND P1'. ALSO HAS THE REMARK 400 ABILITY TO CLOT MILK. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 2431 O HOH A 2436 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 52 CD GLU A 52 OE2 0.070 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 SUI A 54 CA - C - N ANGL. DEV. = -44.6 DEGREES REMARK 500 TYR A 58 CB - CG - CD2 ANGL. DEV. = 4.0 DEGREES REMARK 500 ASP A 118 CB - CG - OD2 ANGL. DEV. = -6.8 DEGREES REMARK 500 ASP A 145 CB - CG - OD2 ANGL. DEV. = -5.9 DEGREES REMARK 500 ASP A 275 CB - CG - OD2 ANGL. DEV. = -7.9 DEGREES REMARK 500 TYR A 276 CB - CG - CD1 ANGL. DEV. = 4.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 319 171.68 -58.43 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2024 DISTANCE = 6.05 ANGSTROMS REMARK 525 HOH A2029 DISTANCE = 6.31 ANGSTROMS REMARK 525 HOH A2030 DISTANCE = 7.84 ANGSTROMS REMARK 525 HOH A2032 DISTANCE = 7.53 ANGSTROMS REMARK 525 HOH A2035 DISTANCE = 8.43 ANGSTROMS REMARK 525 HOH A2073 DISTANCE = 8.41 ANGSTROMS REMARK 525 HOH A2076 DISTANCE = 6.24 ANGSTROMS REMARK 525 HOH A2105 DISTANCE = 6.26 ANGSTROMS REMARK 525 HOH A2130 DISTANCE = 6.68 ANGSTROMS REMARK 525 HOH A2159 DISTANCE = 6.02 ANGSTROMS REMARK 525 HOH A2263 DISTANCE = 6.28 ANGSTROMS REMARK 525 HOH A2410 DISTANCE = 6.09 ANGSTROMS REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 SER A 401 REMARK 700 REMARK 700 SHEET REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, REMARK 700 TWO SHEETS ARE DEFINED. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SER A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE THR A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 410 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 504 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1E5O RELATED DB: PDB REMARK 900 ENDOTHIAPEPSIN COMPLEX WITH INHIBITOR DB2 REMARK 900 RELATED ID: 1E80 RELATED DB: PDB REMARK 900 ENDOTHIAPEPSIN COMPLEX WITH RENIN INHIBITOR MERCK-KGAA-EMD56133 REMARK 900 RELATED ID: 1E81 RELATED DB: PDB REMARK 900 ENDOTHIAPEPSIN COMPLEX WITH RENIN INHIBITOR MERCK-KGAA-EMD61395 REMARK 900 RELATED ID: 1E82 RELATED DB: PDB REMARK 900 ENDOTHIAPEPSIN COMPLEX WITH RENIN INHIBITOR MERCK-KGAA-EMD59601 REMARK 900 RELATED ID: 1EED RELATED DB: PDB REMARK 900 ENDOTHIAPEPSIN COMPLEX WITH THE CYCLOHEXYL RENIN INHIBITOR PD125754 REMARK 900 RELATED ID: 1ENT RELATED DB: PDB REMARK 900 ENDOTHIAPEPSIN COMPLEX WITH THE INHIBITOR PD130328 REMARK 900 RELATED ID: 1EPL RELATED DB: PDB REMARK 900 RELATED ID: 1EPM RELATED DB: PDB REMARK 900 RELATED ID: 1EPN RELATED DB: PDB REMARK 900 RELATED ID: 1EPO RELATED DB: PDB REMARK 900 RELATED ID: 1EPP RELATED DB: PDB REMARK 900 RELATED ID: 1EPQ RELATED DB: PDB REMARK 900 RELATED ID: 1EPR RELATED DB: PDB REMARK 900 RELATED ID: 1ER8 RELATED DB: PDB REMARK 900 RELATED ID: 1GKT RELATED DB: PDB REMARK 900 NEUTRON LAUE DIFFRACTION STRUCTURE OF ENDOTHIAPEPSIN COMPLEXED WITH REMARK 900 TRANSITION STATE ANALOGUE INHIBITOR H261 REMARK 900 RELATED ID: 1GVT RELATED DB: PDB REMARK 900 ENDOTHIAPEPSIN COMPLEX WITH CP-80,794 REMARK 900 RELATED ID: 1GVU RELATED DB: PDB REMARK 900 ENDOTHIAPEPSIN COMPLEX WITH H189 REMARK 900 RELATED ID: 1GVV RELATED DB: PDB REMARK 900 FIVE ATOMIC RESOLUTION STRUCTURES OF ENDOTHIAPEPSIN INHIBITOR REMARK 900 COMPLEXES; IMPLICATIONS FOR THE ASPARTIC PROTEINASE MECHANISM REMARK 900 RELATED ID: 1GVW RELATED DB: PDB REMARK 900 ENDOTHIAPEPSIN COMPLEX WITH PD-130,328 REMARK 900 RELATED ID: 1GVX RELATED DB: PDB REMARK 900 ENDOTHIAPEPSIN COMPLEXED WITH H256 REMARK 900 RELATED ID: 1OD1 RELATED DB: PDB REMARK 900 ENDOTHIAPEPSIN PD135,040 COMPLEX REMARK 900 RELATED ID: 1OEX RELATED DB: PDB REMARK 900 ATOMIC RESOLUTION STRUCTURE OF ENDOTHIAPEPSIN IN COMPLEX WITH A REMARK 900 HYDROXYETHYLENE TRANSITION STATE ANALOGUE INHIBITOR H261 REMARK 900 RELATED ID: 2ER0 RELATED DB: PDB REMARK 900 RELATED ID: 2ER6 RELATED DB: PDB REMARK 900 RELATED ID: 2ER7 RELATED DB: PDB REMARK 900 RELATED ID: 2ER9 RELATED DB: PDB REMARK 900 RELATED ID: 3ER3 RELATED DB: PDB REMARK 900 RELATED ID: 3ER5 RELATED DB: PDB REMARK 900 RELATED ID: 4APE RELATED DB: PDB REMARK 900 RELATED ID: 4ER1 RELATED DB: PDB REMARK 900 RELATED ID: 4ER2 RELATED DB: PDB REMARK 900 RELATED ID: 4ER4 RELATED DB: PDB REMARK 900 RELATED ID: 5ER1 RELATED DB: PDB REMARK 900 RELATED ID: 5ER2 RELATED DB: PDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 ASP A54 AND GLY A55 HAVE CYCLISED TO FORM A SUCCINIMIDE DBREF 1OEW A 1 329 UNP P11838 CARP_CRYPA 90 419 SEQRES 1 A 329 SER THR GLY SER ALA THR THR THR PRO ILE ASP SER LEU SEQRES 2 A 329 ASP ASP ALA TYR ILE THR PRO VAL GLN ILE GLY THR PRO SEQRES 3 A 329 ALA GLN THR LEU ASN LEU ASP PHE ASP THR GLY SER SER SEQRES 4 A 329 ASP LEU TRP VAL PHE SER SER GLU THR THR ALA SER GLU SEQRES 5 A 329 VAL SUI GLN THR ILE TYR THR PRO SER LYS SER THR THR SEQRES 6 A 329 ALA LYS LEU LEU SER GLY ALA THR TRP SER ILE SER TYR SEQRES 7 A 329 GLY ASP GLY SER SER SER SER GLY ASP VAL TYR THR ASP SEQRES 8 A 329 THR VAL SER VAL GLY GLY LEU THR VAL THR GLY GLN ALA SEQRES 9 A 329 VAL GLU SER ALA LYS LYS VAL SER SER SER PHE THR GLU SEQRES 10 A 329 ASP SER THR ILE ASP GLY LEU LEU GLY LEU ALA PHE SER SEQRES 11 A 329 THR LEU ASN THR VAL SER PRO THR GLN GLN LYS THR PHE SEQRES 12 A 329 PHE ASP ASN ALA LYS ALA SER LEU ASP SER PRO VAL PHE SEQRES 13 A 329 THR ALA ASP LEU GLY TYR HIS ALA PRO GLY THR TYR ASN SEQRES 14 A 329 PHE GLY PHE ILE ASP THR THR ALA TYR THR GLY SER ILE SEQRES 15 A 329 THR TYR THR ALA VAL SER THR LYS GLN GLY PHE TRP GLU SEQRES 16 A 329 TRP THR SER THR GLY TYR ALA VAL GLY SER GLY THR PHE SEQRES 17 A 329 LYS SER THR SER ILE ASP GLY ILE ALA ASP THR GLY THR SEQRES 18 A 329 THR LEU LEU TYR LEU PRO ALA THR VAL VAL SER ALA TYR SEQRES 19 A 329 TRP ALA GLN VAL SER GLY ALA LYS SER SER SER SER VAL SEQRES 20 A 329 GLY GLY TYR VAL PHE PRO CYS SER ALA THR LEU PRO SER SEQRES 21 A 329 PHE THR PHE GLY VAL GLY SER ALA ARG ILE VAL ILE PRO SEQRES 22 A 329 GLY ASP TYR ILE ASP PHE GLY PRO ILE SER THR GLY SER SEQRES 23 A 329 SER SER CYS PHE GLY GLY ILE GLN SER SER ALA GLY ILE SEQRES 24 A 329 GLY ILE ASN ILE PHE GLY ASP VAL ALA LEU LYS ALA ALA SEQRES 25 A 329 PHE VAL VAL PHE ASN GLY ALA THR THR PRO THR LEU GLY SEQRES 26 A 329 PHE ALA SER LYS MODRES 1OEW SUI A 54 ASP MODRES 1OEW SUI A 54 GLY HET SUI A 54 11 HET SER A 401 6 HET THR A 402 8 HET GOL A 410 6 HET SO4 A 500 5 HET SO4 A 501 5 HET SO4 A 502 5 HET SO4 A 503 5 HET SO4 A 504 5 HETNAM SUI (3-AMINO-2,5-DIOXO-1-PYRROLIDINYL)ACETIC ACID HETNAM SER SERINE HETNAM THR THREONINE HETNAM GOL GLYCEROL HETNAM SO4 SULFATE ION HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 1 SUI C6 H8 N2 O4 FORMUL 2 SER C3 H7 N O3 FORMUL 3 THR C4 H9 N O3 FORMUL 4 GOL C3 H8 O3 FORMUL 5 SO4 5(O4 S 2-) FORMUL 10 HOH *609(H2 O) HELIX 1 1 THR A 49 VAL A 53 5 5 HELIX 2 2 THR A 59 SER A 63 5 5 HELIX 3 3 SER A 112 ASP A 118 1 7 HELIX 4 4 PHE A 129 ASN A 133 5 5 HELIX 5 5 THR A 142 LYS A 148 1 7 HELIX 6 6 PRO A 227 ALA A 236 1 10 HELIX 7 7 PRO A 273 ILE A 277 1 5 HELIX 8 8 GLY A 305 LYS A 310 1 6 SHEET 1 AA 3 LYS A 67 SER A 77 0 SHEET 2 AA 3 SER A 83 VAL A 95 -1 O SER A 84 N ILE A 76 SHEET 3 AA 3 TYR A 17 ILE A 23 -1 O GLN A 22 N SER A 94 SHEET 1 AB 7 LYS A 67 SER A 77 0 SHEET 2 AB 7 SER A 83 VAL A 95 -1 O SER A 84 N ILE A 76 SHEET 3 AB 7 LEU A 98 VAL A 111 -1 O LEU A 98 N VAL A 95 SHEET 4 AB 7 LEU A 41 VAL A 43 1 O LEU A 41 N GLU A 106 SHEET 5 AB 7 GLY A 123 GLY A 126 -1 O LEU A 124 N TRP A 42 SHEET 6 AB 7 GLN A 28 ASP A 35 1 O ASP A 33 N LEU A 125 SHEET 7 AB 7 TYR A 17 ILE A 23 -1 O THR A 19 N LEU A 32 SHEET 1 AC 7 ALA A 268 ILE A 272 0 SHEET 2 AC 7 PHE A 261 VAL A 265 -1 O PHE A 261 N ILE A 272 SHEET 3 AC 7 GLU A 195 VAL A 203 -1 N THR A 199 O GLY A 264 SHEET 4 AC 7 LYS A 209 ALA A 217 -1 O LYS A 209 N TYR A 201 SHEET 5 AC 7 ASN A 302 PHE A 304 1 O ASN A 302 N ILE A 216 SHEET 6 AC 7 LEU A 224 LEU A 226 -1 O TYR A 225 N ILE A 303 SHEET 7 AC 7 ILE A 293 SER A 295 1 O GLN A 294 N LEU A 226 SHEET 1 AD 4 LYS A 242 SER A 244 0 SHEET 2 AD 4 GLY A 249 PRO A 253 -1 O GLY A 249 N SER A 244 SHEET 3 AD 4 SER A 288 GLY A 291 -1 O CYS A 289 N PHE A 252 SHEET 4 AD 4 ASP A 278 PRO A 281 -1 N PHE A 279 O PHE A 290 SSBOND 1 CYS A 254 CYS A 289 1555 1555 2.03 LINK C VAL A 53 N SUI A 54 1555 1555 1.32 LINK C SUI A 54 N GLN A 55 1555 1555 1.32 CISPEP 1 THR A 25 PRO A 26 0 -9.15 CISPEP 2 SER A 136 PRO A 137 0 5.89 SITE 1 AC1 7 GLY A 37 TYR A 78 GLY A 79 ILE A 216 SITE 2 AC1 7 ASP A 218 THR A 402 HOH A2586 SITE 1 AC2 6 GLY A 37 SER A 77 SER A 401 HOH A2587 SITE 2 AC2 6 HOH A2588 HOH A2589 SITE 1 AC3 6 CYS A 254 ASP A 278 GLY A 280 PRO A 281 SITE 2 AC3 6 CYS A 289 HOH A2590 SITE 1 AC4 8 TYR A 178 SER A 181 ILE A 182 HOH A2413 SITE 2 AC4 8 HOH A2591 HOH A2592 HOH A2593 HOH A2594 SITE 1 AC5 9 SER A 112 SER A 113 THR A 320 THR A 321 SITE 2 AC5 9 HOH A2310 HOH A2595 HOH A2596 HOH A2597 SITE 3 AC5 9 HOH A2598 SITE 1 AC6 5 SER A 136 PRO A 137 HOH A2599 HOH A2600 SITE 2 AC6 5 HOH A2601 SITE 1 AC7 8 ALA A 268 ARG A 269 SER A 283 HOH A2415 SITE 2 AC7 8 HOH A2544 HOH A2581 HOH A2602 HOH A2603 SITE 1 AC8 6 LYS A 141 HOH A2604 HOH A2605 HOH A2606 SITE 2 AC8 6 HOH A2608 HOH A2609 CRYST1 42.720 74.660 42.550 90.00 97.27 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023408 0.000000 0.002986 0.00000 SCALE2 0.000000 0.013394 0.000000 0.00000 SCALE3 0.000000 0.000000 0.023692 0.00000